Latest California Healthline Stories
How high-cost drugs are impacting California.
Two state senators and a health foundation executive offer their perspectives.
Valeant Pharmaceuticals, the company that makes Seconal, the drug most commonly used in prescribed for terminally ill patients who want to end their lives, physician-assisted suicide, has doubled the price to more than $3,000.
Seniors slammed with big premium increases face tough choices.
As baby boomers grow old, demand for long-term care is expected to explode. But it is expensive, and the patchwork system that pays for it now won’t be sustainable for much longer. A debate about new ways to finance it is heating up.
Once bound for the hazardous waste incinerator, surplus pharmaceuticals are directed to people who find it hard to pay for prescriptions.
Researchers found little difference in patient outcomes or satisfaction after placing restraints on medical residents’ working conditions in the past decade. Officials have previously sought to prevent inexperienced doctors from making mistakes caused by fatigue.
California cities increasingly are billing patients for paramedic services that they say were not covered by insurers. One 85-year-old woman took on city hall.
Californians are evenly split on whether the state’s $2 billion surplus should go toward paying off debt or restoring social service programs, according to a survey released yesterday.
Heated battle expected over November ballot proposal to curb state’s prescription drug costs, as pharmaceutical industry opens its pocketbook to defeat the measure.